Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - Investigator  + (2.3.1)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure  + (2.3.1)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi)  + (2.3.1)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.60-001  + (2.3.1)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.64-001  + (2.3.1)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (e)  + (2.3.1)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (i)  + (2.3.1)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (4)  + (2.3.1)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart E  + (2.3.1)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.3  + (2.3.2)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.1  + (2.3.2)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.6  + (2.3.2)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 6.1  + (2.3.2)
• Reference:EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Organisation  + (2.3.2)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 49  + (2.3.2)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-002  + (2.3.2)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 62 Paragraph 4  + (2.3.2)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72  + (2.3.2)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68  + (2.3.2)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 5-002  + (2.3.2)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 7 – 8  + (2.3.2)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 1.12  + (2.3.2)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-001  + (2.3.2)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 3 Absatz 5 – 6  + (2.3.2)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-002  + (2.3.2)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-001  + (2.3.2)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 65  + (2.3.2)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (viii)  + (2.3.2)
• Reference:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A.  + (2.3.2)

• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.2  + (2.3.3)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.7  + (2.3.3)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.3  + (2.3.3)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 50  + (2.3.3)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 3 3.9  + (2.3.3)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 6 6.4  + (2.3.3)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (d)  + (2.3.3)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 3 Part 1 1.  + (2.3.3)

• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.5  + (2.3.4)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Agreement  + (2.3.4)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.6  + (2.3.4)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.14-001  + (2.3.4)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - contract  + (2.3.4)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.11  + (2.3.4)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 6.9  + (2.3.4)
• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 33  + (2.3.4)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.7.7  + (2.3.4)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 9  + (2.3.4)
• Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1121-3-1  + (2.3.4)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (k)-(l)  + (2.3.4)
• Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 Templates  + (2.3.4)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c)  + (2.3.4)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (5)  + (2.3.4)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 9  + (2.4.0)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.7.1-001  + (2.4.0)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - escape treatment  + (2.4.0)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.1  + (2.4.0)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.7  + (2.4.0)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 1 (f)  + (2.4.0)